|
|
|
Volumn , Issue 51, 2003, Pages 1-4
|
|
Treating osteoporosis with teriparatide: many unknowns?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
PARATHYROID HORMONE[1-34];
ADULT;
ANIMAL;
ARTICLE;
BONE DENSITY;
CANADA;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DRUG COST;
DRUG EFFECT;
ECONOMICS;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
HUMAN;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
RAT;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED STATES;
ADULT;
ALENDRONATE;
ANIMALS;
BONE DENSITY;
CANADA;
CLINICAL TRIALS, PHASE III;
DRUG COSTS;
FEMALE;
FRACTURES, BONE;
HUMANS;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
RANDOMIZED CONTROLLED TRIALS;
RATS;
RISK FACTORS;
TERIPARATIDE;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0642370856
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
